Scientific article
OA Policy
French

Indications off-label des traitements biologiques en dermatologie

Published in

Revue médicale suisse, vol. 12, no. 512, p. 635-638

Publication date

2016

Abstract

Last years, the development of biological drugs substantially improved the outcome of many inflammatory diseases. In dermatology, this kind of therapy is essentially prescribed for the treatment of psoriasis, and include the anti-TNF, anti-IL-12/IL-23 and anti-IL-17. Despite these treatments have not yet been approved, they seemed to be efficient for the treatment of many other inflammatory dermatosis, like granulomatous diseases, neutrophilic diseases, hydradenitis suppurativa or pityriasis rubra pilaris.

Keywords

  • Biological Products/therapeutic use
  • Dermatology/trends
  • Granuloma/drug therapy
  • Humans
  • Off-Label Use
  • Pityriasis Rubra Pilaris/drug therapy
  • Psoriasis/drug therapy
  • Skin Diseases/drug therapy

UNIGE research groups

Citation (ISO format)

CORTES SANCHEZ, Begonia, LAFFITTE, Emmanuel Alexis. Indications off-label des traitements biologiques en dermatologie. In: Revue médicale suisse, 2016, vol. 12, n° 512, p. 635–638.

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1660-9379
414views
277downloads

Technical informations

Creation

28/09/2017 15:31:00

First validation

28/09/2017 15:31:00

Update

24/01/2025 16:03:54

Status update

24/01/2025 16:03:54

Last indexation

24/01/2025 16:09:33
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated